| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |